Neurological Disorders: Language & Behavior Issues
Studies discussed include neuropsychiatric symptoms leading to mild cognitive impairment and gesture comprehension and language in children with autism.
Aging and Dementia: AAN 2017
Studies examined the impact of blood pressure trajectories on dementia risk and explored the relationship between sleep apnea and Aβ accumulations.
Interesting Neuro: Stroke Warning & Cluster Headache
May news includes ground-breaking FDA approvals, predictions of Alzheimer disease, and a possible biomarker for mild traumatic brain injury.
Epilepsy Highlights: AAN 2017
Highlights: imaging the temporal dynamics & cellular architecture of seizures in Dravet syndrome, & reducing risk of spontaneous fetal loss.
Chronic Traumatic Encephalopathy: Potential Biomarker
Blood protein analysis of plasma total tau has diagnostic use in Alzheimer disease. Could the same hold true for CTE?
Acute Stroke Treatment and Outcomes: AAN 2017
The effect of blood pressure on IAT safety and benefit and pediatric stroke outcomes based on treatment were some of the studies presented at AAN.
Migraine Prevention: Promising New Drug
Peter Goadsby, MD discusses the efficacy, safety, & tolerability of the CGRP inhibitor erenumab in a phase III trial of participants with episodic migraine.
New SUDEP Guidelines Clarify Risk Factors
The new SUDEP guidelines, co-developed by the AAN & AES and presented this week at the AAN Annual Meeting, provide clarity to health professionals.
Parkinson Disease: Genetic Findings
Research at AAN 2017 highlights research of genes that may help predict the likelihood of developing Parkinson disease and progression of the disease.
Lennox-Gastaut Syndrome: Cannabidiol Treatment
What was the impact of add-on cannabidiol treatment in patients aged 2-55 years experiencing drop seizures?
AAN 2017: Must-See Sessions
You won’t want to miss these new features and sessions at this year’s American Academy of Neurology Annual Meeting, April 22-28, in Boston, MA.
Interesting Neuro: New Drugs & TBI Recovery
April news includes tools to manage brain injury and predict recovery, new drug hits and misses, and an updated epilepsy classification system.
IBIA 2017: Repercussions of TBI
Research presented at IBIA 2017 looked at risk behavior in adolescents, return to work, and maladaptive emotion regulation following TBI.
ACC 2017: Late-Breaking Clinical Trials
Research includes safety of digoxin with atrial fibrillation, comparison of cerebral embolic protection devices, and cerebral microbleed triggers.
ACC 2017: CV Risk Factors
Research includes a possible link between Zika & CV issues, CV effects of cannabis use, and neurocognitive impairment with PCSK9 variants.
Interesting Neuro: Tumor Tx and Stroke Recovery
March news includes possible brain tumor therapies, a study exploring mechanisms underlying demyelination-induced seizures, and VNS post stroke.
ACTRIMS 2017 Forum: MS Treatment Clinical Trials
Research examined no evidence of disease activity and no evidence of progression with ocrelizumab as well as long-term results with mitoxantrone.
ISC 2017: Vascular Cognitive Impairment
Research included the impact of diet on cognitive decline and the degree of a link between depression & dementia post intracerebral hemorrhage.
Interesting Neuro: Stroke Risks & Treatment
February news includes stroke risk with Alzheimer disease & migraine, neonatal hemorrhagic stroke, and head trauma in sports.
Interesting Neuro: Epilepsy Outcomes & Vitamin D
January news includes the first FDA-approved drug for spinal muscular atrophy, various epilepsy treatments & vitamin D’s impact on Alzheimer & headache.
Top 10: Neurology Times 2016
From Alzheimer disease to Zika virus, we’ve compiled a list of this year’s most popular articles on Neurology Times.
Impact of Epilepsy on Other Neurological Disorders
Research from AES 2016 explored relationships between epilepsy and other neurological disorders, including Alzheimer disease, MS, stroke, and autism.
Interesting Neuro: Tau Vaccine & Winter Zika Risk
November news includes the first human clinical trial focusing on tau in Alzheimer disease and Zika-related microcephaly not presenting at birth.
AES 2016: Young Investigator Award Research
Award-winning basic, translational, or clinical epilepsy research covered cannabidiol treatment, outcome predictions, imaging studies, and more.
AES 2016: Pregnancy in Women with Epilepsy
Careful planning and monitoring is important for women with epilepsy who become pregnant. Several studies from AES 2016 address pregnancy issues.
Post-Stroke Epilepsy: Risk Factors
Up to 45% of stroke victims over the age of 60 will develop epilepsy. Researchers at AES 2016 presented risk factors of post-stroke epilepsy.
AES 2016: Top 10 Sessions
From surgical procedure selection to multiscale imaging to use of the latest drugs, we present a list of 10 not-to-be-missed sessions at AES 2016.
AHA 2016: Cardiovascular Health and Cognition
Do lipid-lowering medications or low vitamin D levels in mid-life cause neurocognitive deficits? What effect does hypotension have on TBI outcomes?
AHA 2016: Stroke & Atrial Fibrillation Risks
Psychological stressors, air pollution, and cardiorespiratory fitness were some of the stroke and AF risk factors researchers investigated.
Effect of Lower BP & Cholesterol on Cognition
The HOPE-3 study examined the effects of blood pressure- and lipid-lowering medications to prevent CV outcomes. How was cognitive function affected?
2 Clarke Drive Cranbury, NJ 08512